Gökhan AYTEKİN, Selma EROL AYTEKİN, Hüseyin TOKGÖZ, Ümran ÇALIŞKAN

Single center 10 years’ experience of acute lymphoblastic leukemia in childhood: Retrospective cohort study

Aim: We reviewed the files of 188 patients diagnosed with acute lymphoblastic leukemia at Pediatric Hematology Department,Necmettin Erbakan University Faculty of Medicine, Konya, between April 2006 and April 2016 retrospectively. 167 patients, whohad sufficient records and accepting to participate in the study, were included. Patients were classified 3 groups according to theirtreatment protocols. These protocols were Saint Jude Total Therapy (St. Jude) protocol, Berlin-Frankfurt-Munster 2000 (BFM 2000)protocol and BFM 2009 protocol. Acute lymphoblastic leukemia (ALL) is a malignant disorder characterized with clonal enlargementof lymphoid progenitor cells. It is most common malignancy in childhood. Recent developments in immunologic and geneticmethods have significantly altered the diagnostic and classification approaches. Nowadays advanced studies such as immunologicand cytogenetic studies have become more important in prognosis and treatment response. In this study, we aimed to presentthe clinical and laboratory features of patient with ALL who were followed in our Pediatric Hematology Clinic (Necmettin ErbakanUniversity Faculty of Medicine, Konya) and determine the factors affecting the mortality and morbidity in patients with ALL.Results: When the results of the study were evaluated, we found that uric acid levels, blast ratio on the 15th day bone marrowevaluation, presence of relapse and relapse type were effective on overall survival. Also, we found that blast ratio on 15th day bonemarrow evaluation, high levels of uric acid, and lactate dehydrogenase (LDH) were effective for event-free survival.Conclusion: In conclusion, our overall survival and disease-free survival rates are similar to those performed by St. Jude Totaltherapy XIIIB, BFM 2000 and BFM 2009 protocol.

PDF

___

1. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;37:1030-43.
2. Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA: A cancer journal for clinicians 2014;64:83-103.
3. Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatric clinics of North America 2015;62:47-60.
4. Svendsen AL, Feychting M, Klaeboe L, et al. Time trends in the incidence of acute lymphoblastic leukemia among children 1976-2002: a populationbased Nordic study. The J Pediatrics 2007;151:548- 50.
5. Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood 2012;119:34-43.
6. Pui CH, Sandlund JT, Pei D et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children’s Research Hospital. Blood 2004;104:2690-6.
7. Stary J, Zimmermann M, Campbell M et al. Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002, 2013.
8. Schrappe M, Reiter A, Ludwig WD et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. GermanAustrian-Swiss ALL-BFM Study Group. Blood 2000;95:3310-22.
9. Gatta G, Capocaccia R, Stiller C et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23:3742-51.
10. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: a cancer journal for clinicians 2011;61:212-36.
11. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. The New England J Med 2009;360:2730- 41.
12. Hazar V, Karasu GT, Uygun V, et al. Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience. Journal of pediatric hematology/oncology 2010;32:317-22.
13. Atay A, Kürekci E, Kesik V et al. Akut lenfoblastik lösemili olgularimizin retrospektif analizi. Gülhane Tip Dergisi 2005;47:183-6.
14. Pui CH, Williams DL, Kalwinsky DK et al. Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia. Blood 1986;67:1688-92.
15. Bassan R, Gatta G, Tondini C, et al. Adult acute lymphoblastic leukaemia. Critical reviews in oncology/ hematology 2004;50:223-61.
16. Crews KR, Zhou Y, Pauley JL et al. Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia. Cancer 2010;116:227- 32.
17. Margolin J, Rabin K, Steuber C, et al. Acute lymphoblastic leukemia. In: Pizzo P, Poplack D, editors. Acute lymphoblastic leukemia. Philadelphia: ippincott Williams & Wilkins 2011:518-65.
18. PL. Leukemias. In: P L, editor Manual of Pediatric Hematology Oncology. 6th ed: Elseiver Academic Pres 2005:415-50.
19. Aziz Z, Zahid M, Mahmood R, et al. Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis. Medical and Pediatric Oncology 1997;28:48-53.
20. Hoelzer D, Bassan R, Dombret H et al. Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 2016;27:69-82.
21. Rubnitz JE, Pui CH. Childhood Acute Lymphoblastic Leukemia. The oncologist 1997;2:374-80.
22. Wei W, Chen X, Zou Y et al. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China. BMC Pediatrics 2015;15:80.
23. Moricke A, Reiter A, Zimmermann M et al. Riskadjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008;111:4477-89.
24. Bajel A, George B, Mathews V et al. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatric blood & cancer 2008;51:621-5.